Future studies targeting Mfn1 in the setting of weight loss surgery will better define the mechanisms that link mitochondrial architecture to bioenergetic adaptations in liver, and mitochondrial dynamics proteins may emerge as a new functional target for the treatment of obesity and liver‐related disorders. This evidence concerns the gene MFN1 and obesity due to melanocortin 4 receptor deficiency.